-
Biogen Inc. (BIIB $171.50)
-
Pfizer Inc. (PFE $25.53)
-
Knight Therapeutics Inc. (GUD $6.08)
-
Theratechnologies Inc. (TH $4.47)
Q: With the patent protection now extended for drugs for two years longer, do you have any suggestions as to co's in that space that might benefit?